Pharmacotherapy of attention-deficit/hyperactivity disorder: Nonstimulant medication approaches

Expert Review of Neurotherapeutics

Volumn 7, Issue 2, 2007, Pages 195-201

  Mohammadi, Mohammad Reza ^a   Akhondzadeh, Shahin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ADHD; Alternative medicine; Attention deficit hyperactivity disorder; Etiology; Nonstimulants; Pharmacotherapy

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; BUSPIRONE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; DONEPEZIL; EQUASYM; FLUOXETINE; GINKGO BILOBA EXTRACT; GUANFACINE; MANIFAXINE; METHYLPHENIDATE; MOCLOBEMIDE; MODAFINIL; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PASSIFLORA INCARNATA EXTRACT; PEMOLINE; PHENELZINE; PLACEBO; PSYCHOSTIMULANT AGENT; SELEGILINE; STATTERA; THEOPHYLLINE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; VENLAFAXINE;

APPETITE; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DEMENTIA; DIAGNOSTIC PROCEDURE; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPOTENSION; INSOMNIA; IRRITABILITY; LIVER TOXICITY; META ANALYSIS; MOOD CHANGE; NAUSEA; PATHOGENESIS; PREVALENCE; PRURITUS; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN MANIFESTATION; SLEEP DISORDER; STOMACH PAIN; SWEATING; SYSTEMATIC REVIEW; TIC; UNSPECIFIED SIDE EFFECT; URINE RETENTION; WEIGHT REDUCTION; XEROSTOMIA; ALTERNATIVE MEDICINE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMPLEMENTARY THERAPIES; HUMANS; PREVALENCE;

EID: 33847336975     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.7.2.195     Document Type: Review

References (45)

1. National Institutes of Health Consensus Development Conference Statement. Diagnosis and treatment of attention-deficit/ hyperactivity disorder (ADHD). J. Am. Acad. Child Adolesc. Psychiatry 39, 182-193 (2000).
2. Scahill L. Epidemiology of ADHD in school-age children. Child Adolesc. Psychiatry Clin. North Am. 9, 541-555 (2000).
3. Barkley RA. Attention-deficit hyperactivity disorder. Scientific Am. 8, 44-52 (1998).
4. Fox AM, Mahoney WJ. Children with School Problems. Canadian Paediatric Society, Ottawa, Canada (1998).
5. American Academy of Pediatrics, Committee on Quality Improvement. Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105, 1158-1170 (2000).
6. Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (2nd Edition). Guilford Press, NY, USA (1998).
7. Goldman L, Genel M, Bezman R, Slanetz P. Diagnosis and treatment of attention deficit/hyperactivity disorder in children and adolescents. JAMA 279, 1100-1107 (1998).
8. Mercuglioano M. What is attention-deficit/ hyperactivity disorder? Pediatric Clin. N. Am. 46, 831-843 (1999).
9. Spencer T, Biederman J, Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatric Clin. N. Am. 46, 915-927 (1999).
10. Richard W, Root II, Robert J, Resnick J. An update on the diagnosis and treatment of attention-deficit/hyperactivity disorder in children. Prof. Psychol. Res. Pr. 34, 34-41 (2003).
11. Owens J, Hoza B. Diagnostic utility of DSM-IV-TR symptoms in the prediction of DSM-IV-TR ADHD subtypes and ODD. J. Atten. Dis. 7, 11-27 (2003).
12. Staller J, Faraone SV. Attention-deficit hyperactivity disorder in girls: epidemiology and management. CNS Drugs 20, 107-123 (2006).
13. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J. Am. Acad. Child Adolesc. Psychiatry 36, 1036-1045 (1997).
14. Biederman J, Faraone S, Mick E, Williamson S. Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J. Am. Acad. Child Adolesc. Psychiatry 38, 966-975 (1999).
15. Nadeau K, Littman EB, Quinn PQ. Understanding Girls with Attention Deficit Hyperactivity Disorder. Bruner/Mazel, NY, USA (2000).
16. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders (4th Edition). American Psychiatric Association, Washington, USA (1994).
17. Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J. Child Psychol. Psychiatry 39, 65-99 (1998).
18. Pliszka SR, McCracken JT, Maas JW. Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J. Am. Acad. Child Adolesc. Psychiatry 35, 264-272 (1996).
19. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63, 1767-1776 (1998).
20. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J. Am. Acad. Child Adolesc. Psychiatry 41, 378-385 (2002).
21. Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am. J. Psychiatry 160, 1028-1040 (2003).
22. American Academy of Pediatrics. Subcommittee on Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement. Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108, 1033-1044 (2001).
23. MTA Cooperative Group. 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch. Gen. Psychiatry 56, 1073-1086 (1999).
24. Greenhill L, Pliszka S, Dulcan MK. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J. Am. Acad. Child Adolesc. Psychiatry 41, S26-S49 (2002).
25. Angold AJ. Stimulant treatment for children: a community perspective. J. Am. Acad. Child Adolesc. Psychiatry 39, 975-984 (2000).
26. American Academy of Pediatrics, Committee on Quality Improvement. Clinical practice guidelines: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108, 1033-1044 (2001).
27. Biederman J. Practical considerations in stimulant drug selection for the attentiondeficit/ hyperactivity disorder patient - efficacy, potency, and titration. Today's Therapeutic Trends 20, 311-328 (2002).
28. Findling RL, Dogin JW. Psychopharmacology of ADHD: children and adolescents. J. Clin. Psychiatry 59, 42-49 (1998).
29. Greenhill L, Shockey E, Halperin J, March J. Stimulants in Psychiatry (2nd Edition). Tasman A, Kay J, Lieberman JA (Eds). John Wiley & Sons, Ltd, Chichester, England, (2003).
30. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur. Child Adolesc. Psychiatry 13, 102-116 (2004).
31. Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 841-845 (2003).
32. Mohammadi M, Kashani L, Akhondzadeh S, Sahimi Izadian E, Ohadinia S. Efficacy of theophylline compared to methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents: a double blind and randomized trial. J. Clin. Pharm. Ther. 29, 139-144 (2004).
33. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment Study of Children with ADHD. Arch. Gen. Psychiatry 56, 1073-1086 (1999).
34. Wernicke JF, Kratochvil CJ. Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J. Clin. Psychiatry 63, 50-55 (2002).
35. Olvera RL, Pliszka SR, Luh J, Tatum R. An open trial of venlafaxine in the treatment of attentiondeficit/ hyperactivity disorder in children and adolescents. J. Child Adolesc. Psychopharmacol. 6, 241-250 (1996).
36. Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attentiondeficit/ hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 38, 1551-1559 (1999).
37. Scahill L, Chappell PB, Kim YS. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention-deficit/ hyperactivity disorder. Am. J. Psychiatry 158, 1067-1074 (2001).
38. Conners CK, Casat CD, Gualtieri CT et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J. Am. Acad. Child Adolesc. Psychiatry 35, 1314-1321 (1996).
39. Swanson JM, Greenhill LL, Lopez FA et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/ hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J. Clin. Psychiatry 67, 137-147 (2006).
40. Shytle RD, Silver AA, Wilkinson BJ, Sanberg PR. A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder. World J. Biol. Psychiatry 3, 150-155 (2002).
41. Garber SW, Garber MD, Spizman RF. Beyond Ritalin. Harper Collins, NY, USA (1997).
42. Gant C. Complementary medicine approaches to ADHD. Presentation to Annual Conference, American College of Advancement in Medicine (ACAM), Orlando, FL, May 1999; Laguna Hills, CA, ACAM, (1999).
43. Brue, AW, Oakland TD. Alternative treatments for attention deficit hyperactivity disorders: does evidence support their use. Altern. Ther. Med. 8, 68-74 (2002).
44. Pelham WE, Murphy HA. Attention deficit and conduct disorders. In: Pharmacological and Behavioral Treatment: An Integrative Approach. Herson M (Ed.). J Wiley & Sons, NY, USA, 108-148 (1986).
45. Akhondzadeh S, Mohammadi MR, Momeni F. Passiflora incarnata in treatment of attention-deficit hyperactivity disorder in children and adolescents. Therapy 2, 609-614 (2005).